Understanding climate change and infectious disease: is the one health movement enough?

1 University of Reading, School of Agriculture, Policy and Development, Livestock Development Group 1&2 University of Reading, Walker Institute for Climate Research In the coming decades, climate change is predicted to produce a range of direct...

Funding awarded for research projects

Funding awarded for research projects Other work is under way after the BBSRC, along with the Natural Environment Research Council, and 12 industry partners agreed to fund six research projects to improve the sustainability of...

Biological engineers discover new antibiotic candidates

The human body produces many antimicrobial peptides that help the immune system fend off infection. Scientists hoping to harness these peptides as potential antibiotics have now discovered that other peptides in the human body...

WEAPONISING THE FIGHT AGAINST ANTIBIOTIC RESISTANCE

Could faecal transplants be an effective weapon in the fight back against antibiotic resistance? A research team at Guy’s and St Thomas’ NHS Foundation Trust intends to find out, once and for all. By HELEN...

A historical case with modern significance

In the medical field, spectroscopy technology is being used for research into 470-year-old bones which may have relevance to modern-day sufferers of the bone condition rickets. The technology helped scientists confirm that many sailors who...

Hyperactive FOXA1 reprograms endocrine-resistant breast cancer to become metastatic

A team led by researchers at Baylor College of Medicine and Harvard Medical School has unveiled a novel mechanism that helps explain how endocrine-resistant breast cancer acquires metastatic behavior, opening the possibility of new...

Matching clinical trials with unmet clinical need

A new tool that helps target clinical trials to areas of unmet clinical need has sparked interest in both the National Health Service (NHS) and the commercial clinical research world. Stephen Lock, Head of...

Striving to improve rates of reproducibility

Experts in biological sample storage and logistics management, CRYONISS offers a comprehensive storage service at ambient, +4°C, -20°C and -80°C, as well as vapour phase liquid nitrogen. The Cheshire-based Cryoniss team has a wealth of...

Facing a Changing Biosimilar Marketplace

Most people associate passage of the US Patient Protection and Affordable Care Act or ACA, (otherwise known as Obamacare) with extending health benefits to the under- and uninsured. But the legislation, signed into law in...

Controlling Temperature with BioPharma Dynamics

BioPharma Dynamics discuss the importance of controlling parameters in your process. Temperature monitoring and control devices are an integral part of any laboratory within the pharmaceutical sector. Having a quality temperature control system in place...

Better understanding of immunology offers hope for the future

Recent years have seen dramatic strides being taken in the science of immunology – the capacity to direct the body’s natural defences against specific illnesses and conditions. So dramatic have the strides been that scientists’...

The body in miniature

By Craig Brierley at University of Cambridge The past few years has seen an explosion in the number of studies using organoids – so-called ‘mini organs’. While they can help scientists understand human biology and...

Cell therapy manufacturing industry takes big steps forward

Cell Therapy production across the world has made some significant advances in recent months, with investment in manufacture announced and exciting research suggesting new applications. The industry in the UK has taken a step forward...

Focus on Alzheimer’s disease 
– Hope on the horizon

Dr David Reynolds Chief Scientific Officer at Alzheimer’s Research UK Alzheimer’s Research UK is the UK’s leading dementia research charity and is dedicated to funding pioneering research to find ways to understand, diagnose, reduce risk and...

Blocking escape route offers hope to cancer patients

A new drug that blocks cancer’s escape route from chemotherapy could be used to treat lung and pancreatic cancers. Scientists in human cancer cells and in mice have shown that the drug boosts the effectiveness...

The IP journey and risk mitigation

Paul Storer Senior Policy Adviser in the Business Support Policy Team at the IPO Resolving IP disputes can be costly and the Intellectual Property Office continues to seek to reduce costs for businesses, not only in...